Journal article
DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.
- Abstract:
-
Aims To explore the cost-effectiveness of alternative methods of screening family members for hypertrophic cardiomyopathy (HCM), the most common monogenic cardiac disorder and the most frequent cause of sudden cardiac death (SCD) in young people. Methods and results Economic decision model comparing cascade screening by genetic, as opposed to clinical methods. The incremental cost per life year saved was 14,397 euro for the cascade genetic compared with the cascade clinical approach. Genetic ...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- European heart journal
- Volume:
- 31
- Issue:
- 8
- Pages:
- 926-935
- Publication date:
- 2010-04-01
- DOI:
- EISSN:
-
1522-9645
- ISSN:
-
0195-668X
- Source identifiers:
-
66507
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:66507
- UUID:
-
uuid:def93e02-5e5b-4c22-a6de-da6c7c38efe9
- Local pid:
- pubs:66507
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2010
If you are the owner of this record, you can report an update to it here: Report update to this record